Sage to sunset first postpartum depression drug, focus on Zurzuvae
| BHCUX Fund | USD 20.60 0.17 0.83% |
Slightly above 52% of Baron Health's investor base is interested to short. The analysis of overall sentiment of trading Baron Health Care mutual fund suggests that many investors are impartial at this time. Baron Health's investing sentiment can be driven by a variety of factors including economic data, Baron Health's earnings reports, geopolitical events, and overall market trends.
Baron |
Barry Greene is the CEO of Sage Therapeutics. Following a series of disappointing trial results in 2024, Greene said Sage is taking new steps to focus its resources on its most recently approved treatment for postpartum depression.
Read at bizjournals.com
 |
Baron Health Fundamental Analysis
We analyze Baron Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baron Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baron Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Baron Health is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Baron Health Care Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baron Health mutual fund to make a market-neutral strategy. Peer analysis of Baron Health could also be used in its relative valuation, which is a method of valuing Baron Health by comparing valuation metrics with similar companies.
Peers
Baron Health Related Equities
| BRIFX | Baron Real | 0.87 | ||||
| BRIUX | Baron Real | 0.80 | ||||
| BDAUX | Baron Durable | 0.66 | ||||
| BARUX | Baron Asset | 0.03 | ||||
| BWBTX | Baron Wealthbuilder | 0.05 | ||||
| BDFUX | Baron Discovery | 0.06 | ||||
| BEXUX | Baron Emerging | 0.32 | ||||
| BREUX | Baron Real | 0.32 | ||||
| BFGUX | Baron Focused | 0.35 | ||||
| BSCUX | Baron Small | 0.52 |
Other Information on Investing in Baron Mutual Fund
Baron Health financial ratios help investors to determine whether Baron Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baron with respect to the benefits of owning Baron Health security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |